293 related articles for article (PubMed ID: 28886999)
1. Advances in macrocyclic peptide-based antibiotics.
Luther A; Bisang C; Obrecht D
Bioorg Med Chem; 2018 Jun; 26(10):2850-2858. PubMed ID: 28886999
[TBL] [Abstract][Full Text] [Related]
2. The Fellowship of the Rings: Macrocyclic Antibiotic Peptides Reveal an Anti-Gram-Negative Target.
McLaughlin MI; van der Donk WA
Biochemistry; 2020 Feb; 59(4):343-345. PubMed ID: 31909599
[TBL] [Abstract][Full Text] [Related]
3. Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Luther A; Urfer M; Zahn M; Müller M; Wang SY; Mondal M; Vitale A; Hartmann JB; Sharpe T; Monte FL; Kocherla H; Cline E; Pessi G; Rath P; Modaresi SM; Chiquet P; Stiegeler S; Verbree C; Remus T; Schmitt M; Kolopp C; Westwood MA; Desjonquères N; Brabet E; Hell S; LePoupon K; Vermeulen A; Jaisson R; Rithié V; Upert G; Lederer A; Zbinden P; Wach A; Moehle K; Zerbe K; Locher HH; Bernardini F; Dale GE; Eberl L; Wollscheid B; Hiller S; Robinson JA; Obrecht D
Nature; 2019 Dec; 576(7787):452-458. PubMed ID: 31645764
[TBL] [Abstract][Full Text] [Related]
4. A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative Pathogens.
Wood TM; Slingerland CJ; Martin NI
J Med Chem; 2021 Aug; 64(15):10890-10899. PubMed ID: 34283589
[TBL] [Abstract][Full Text] [Related]
5. Ramoplanin. A 16686, A 16686A, MDL 62198.
Drugs R D; 2002; 3(4):271-5. PubMed ID: 12455203
[No Abstract] [Full Text] [Related]
6. Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions.
Schneider T; Müller A; Miess H; Gross H
Int J Med Microbiol; 2014 Jan; 304(1):37-43. PubMed ID: 24119568
[TBL] [Abstract][Full Text] [Related]
7. Total Synthesis and Biological Evaluation of the Glycosylated Macrocyclic Antibiotic Mangrolide A.
Hattori H; Roesslein J; Caspers P; Zerbe K; Miyatake-Ondozabal H; Ritz D; Rueedi G; Gademann K
Angew Chem Int Ed Engl; 2018 Aug; 57(34):11020-11024. PubMed ID: 29943519
[TBL] [Abstract][Full Text] [Related]
8. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase.
Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D
ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757
[TBL] [Abstract][Full Text] [Related]
9. Disulfide-rich macrocyclic peptides as templates in drug design.
Northfield SE; Wang CK; Schroeder CI; Durek T; Kan MW; Swedberg JE; Craik DJ
Eur J Med Chem; 2014 Apr; 77():248-57. PubMed ID: 24650712
[TBL] [Abstract][Full Text] [Related]
10. Building upon Nature's Framework: Overview of Key Strategies Toward Increasing Drug-Like Properties of Natural Product Cyclopeptides and Macrocycles.
Blanco MJ
Methods Mol Biol; 2019; 2001():203-233. PubMed ID: 31134573
[TBL] [Abstract][Full Text] [Related]
11. Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies.
Bashiruddin NK; Suga H
Curr Opin Chem Biol; 2015 Feb; 24():131-8. PubMed ID: 25483262
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and biology of the ramoplanin family of peptide antibiotics.
McCafferty DG; Cudic P; Frankel BA; Barkallah S; Kruger RG; Li W
Biopolymers; 2002; 66(4):261-84. PubMed ID: 12491539
[TBL] [Abstract][Full Text] [Related]
13. Predicting the unpredictable: Recent structure-activity studies on peptide-based macrocycles.
Wahyudi H; McAlpine SR
Bioorg Chem; 2015 Jun; 60():74-97. PubMed ID: 25973779
[TBL] [Abstract][Full Text] [Related]
14. Heterocycles: Versatile control elements in bioactive macrocycles.
Soor HS; Appavoo SD; Yudin AK
Bioorg Med Chem; 2018 Jun; 26(10):2774-2779. PubMed ID: 29735427
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?
Giordanetto F; Kihlberg J
J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773
[TBL] [Abstract][Full Text] [Related]
16. Cyclic peptide therapeutics: past, present and future.
Zorzi A; Deyle K; Heinis C
Curr Opin Chem Biol; 2017 Jun; 38():24-29. PubMed ID: 28249193
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids.
Vetterli SU; Moehle K; Robinson JA
Bioorg Med Chem; 2016 Dec; 24(24):6332-6339. PubMed ID: 27240465
[TBL] [Abstract][Full Text] [Related]
18. A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity.
Rabanal F; Grau-Campistany A; Vila-Farrés X; Gonzalez-Linares J; Borràs M; Vila J; Manresa A; Cajal Y
Sci Rep; 2015 May; 5():10558. PubMed ID: 26024044
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
[TBL] [Abstract][Full Text] [Related]
20. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
Fiers WD; Craighead M; Singh I
ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
